Cyhoeddiadau
Price DB, Voorham J, Brusselle G, Clemens A, Kostikas K, Stephens JW, Park HY, Roche N, Fogel R. Inhaled corticosteroids in COPD and onset of type 2 diabetes and osteoporosis: matched cohort study. NPJ Prim Care Respir Med. 2019 Oct 28;29(1):38. doi: 10.1038/s41533-019-0150-x. PMID: 31659161
Landgraf W, Owens DR, Frier BM, Zhang M, Bolli GB. Fasting C-peptide, a biomarker for hypoglycaemia risk in insulin-naïve people with type 2 diabetes initiating basal insulin glargine 100 U/mL. Diabetes Obes Metab. 2019 Oct 13. doi: 10.1111/dom.13897. [Epub ahead of print]. PMID: 31608548
Aroda VR, Capehorn MS, Chaykin L, Frias JP, Lausvig NL, Macura S, Lüdemann J, Madsbad S, Rosenstock J, Tabak O, Tadayon S, Bain SC. Impact of baseline characteristics and beta-cell function on the efficacy and safety of subcutaneous once-weekly semaglutide: a patient-level, pooled analysis of the SUSTAIN 1-5 trials. Diabetes Obes Metab. 2019 Oct 13. doi: 10.1111/dom.13896. [Epub ahead of print]. PMID: 31608552
Chudleigh RA, Bain SC. Efficacy of newer agents in the glycaemic management of patients with Type 2 Diabetes. Curr Med Res Opin. 2019 Oct 9:1. doi: 10.1080/03007995.2019.1678344. [Epub ahead of print] No abstract available. PMID: 31596638
Dayan CM, Korah M, Tatovic D, Bundy BN, Herold KC. Changing the landscape for type 1 diabetes: the first step to prevention. Lancet. 2019 Oct 5;394(10205):1286-1296. doi: 10.1016/S0140-6736(19)32127-0. Epub 2019 Sep 15. Review. PMID: 31533907
Steg PG, Bhatt DL, Simon T, Fox K, Mehta SR, Harrington RA, Held C, Andersson M, Himmelmann A, Ridderstråle W, Leonsson-Zachrisson M, Liu Y, Opolski G, Zateyshchikov D, Ge J, Nicolau JC, Corbalán R, Cornel JH, Widimský P, Leiter LA; THEMIS Steering Committee and Investigators. Ticagrelor in Patients with Stable Coronary Disease and Diabetes. N Engl J Med. 2019 Oct 3;381(14):1309-1320. doi: 10.1056/NEJMoa1908077. Epub 2019 Sep 1. PMID: PMID: 31475798
Gregory JW. Prevention of Obesity and Metabolic Syndrome in Children. Front Endocrinol (Lausanne). 2019 Oct 1;10:669. doi: 10.3389/fendo.2019.00669. eCollection 2019. Review. PMID: 31632348
Monnier L, Colette C, Owens D. Calibration free continuous glucose monitoring (CGM) devices: Weighing up the benefits and limitations. Diabetes Metab. 2019 Sep 11:101118. doi: 10.1016/j.diabet.2019.101118. [Epub ahead of print] No abstract available. PMID: 31520684
Bhatt DL, Steg PG, Mehta SR, Leiter LA, Simon T, Fox K, Held C, Andersson M, Himmelmann A, Ridderstråle W, Chen J, Song Y, Diaz R, Goto S, James SK, Ray KK, Parkhomenko AN, Kosiborod MN, McGuire DK, Harrington RA; THEMIS Steering Committee and Investigators. Ticagrelor in patients with diabetes and stable coronary artery disease with a history of previous percutaneous coronary intervention (THEMIS-PCI): a phase 3, placebo-controlled, randomised trial. Lancet. 2019 Aug 30. pii: S0140-6736(19)31887-2. doi: 10.1016/S0140-6736(19)31887-2. [Epub ahead of print]. PMID: 31484629
Powell WE, Hanna SJ, Hocter CN, Robinson E, Lewis M, Dunseath G, Luzio S, Howell A, Dayan CM, Wong FS. Detecting autoreactive B cells in the peripheral blood of people with type 1 diabetes using ELISpot. J Immunol Methods. 2019 Aug;471:61-65. doi: 10.1016/j.jim.2019.05.007. Epub 2019 May 29. PMID: 31152768